Lyra Therapeutics, Inc. (LYRA)
0.01
-0.19
(-95.00%)
USD |
OTCM |
Aug 31, 16:00
Lyra Therapeutics Gross Profit Margin (Quarterly) : -1.33K% for Dec. 31, 2025
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.33K% |
| September 30, 2025 | -300.0% |
| June 30, 2025 | -9.29% |
| March 31, 2025 | 30.05% |
| December 31, 2024 | 27.75% |
| September 30, 2024 | 80.00% |
| June 30, 2024 | 75.75% |
| March 31, 2024 | 74.44% |
| December 31, 2023 | 41.78% |
| Date | Value |
|---|---|
| September 30, 2023 | 0.00% |
| June 30, 2023 | 0.00% |
| March 31, 2023 | 30.73% |
| December 31, 2022 | -1.92K% |
| September 30, 2022 | 16.43% |
| June 30, 2022 | 42.86% |
| March 31, 2022 | 40.17% |
| December 31, 2021 | -2.58% |
| September 30, 2021 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.08K% |
| Return on Assets | -56.69% |
| Return on Invested Capital | -88.22% |
| Profit Margin (Quarterly) | -99.30K% |
| Operating Margin (Quarterly) | -98.73K% |
| Return on Net Operating Assets | -147.8% |